Advertisement
Screener

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Repayments of Convertible Debt

3.2 / 5 stars · 53/84 Roast Me

ALNYLAM PHARMACEUTICALS, INC. Repayments of Convertible Debt

ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Repayments of Convertible Debt of $1.15 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-02-12

  • ALNYLAM PHARMACEUTICALS, INC. repayments of convertible debt for the quarter ending 2025-12-31 was $52.25M.
  • ALNYLAM PHARMACEUTICALS, INC. repayments of convertible debt for the quarter ending 2024-12-31 was $0.00.
  • ALNYLAM PHARMACEUTICALS, INC. repayments of convertible debt for fiscal 2025 was $1.15B.
  • ALNYLAM PHARMACEUTICALS, INC. repayments of convertible debt for fiscal 2024 was $0.00.
  • ALNYLAM PHARMACEUTICALS, INC. repayments of convertible debt for fiscal 2023 was $0.00.
Period endRepayments of Convertible Debt 3 monthRepayments of Convertible Debt 9 monthRepayments of Convertible Debt 12 month
2025-12-31$52.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$1.15B
10-K · filed 2026-02-12
2025-09-30$1.10B
10-Q · filed 2025-10-30
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
10-K · filed 2026-02-12
2024-09-30$0.00
10-Q · filed 2025-10-30
2023-12-31$0.00
10-K · filed 2026-02-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10